Wells Fargo’s Foghorn Therapeutics FHTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $98.9K | Buy |
21,043
+4,907
| +30% | +$23.1K | ﹤0.01% | 4794 |
|
2025
Q1 | $58.9K | Buy |
16,136
+295
| +2% | +$1.08K | ﹤0.01% | 4894 |
|
2024
Q4 | $74.8K | Buy |
15,841
+3,958
| +33% | +$18.7K | ﹤0.01% | 4854 |
|
2024
Q3 | $111K | Buy |
11,883
+2,611
| +28% | +$24.3K | ﹤0.01% | 4564 |
|
2024
Q2 | $53.3K | Buy |
9,272
+3,193
| +53% | +$18.4K | ﹤0.01% | 4906 |
|
2024
Q1 | $40.8K | Buy |
6,079
+813
| +15% | +$5.46K | ﹤0.01% | 4959 |
|
2023
Q4 | $34K | Buy |
5,266
+1,200
| +30% | +$7.74K | ﹤0.01% | 4994 |
|
2023
Q3 | $20.3K | Sell |
4,066
-4,416
| -52% | -$22.1K | ﹤0.01% | 5229 |
|
2023
Q2 | $59.7K | Sell |
8,482
-790
| -9% | -$5.56K | ﹤0.01% | 5068 |
|
2023
Q1 | $57.5K | Buy |
9,272
+3,883
| +72% | +$24.1K | ﹤0.01% | 4804 |
|
2022
Q4 | $34.4K | Buy |
5,389
+5,022
| +1,368% | +$32K | ﹤0.01% | 4719 |
|
2022
Q3 | $3K | Sell |
367
-195
| -35% | -$1.59K | ﹤0.01% | 5716 |
|
2022
Q2 | $8K | Sell |
562
-3,544
| -86% | -$50.4K | ﹤0.01% | 5543 |
|
2022
Q1 | $63K | Sell |
4,106
-6,808
| -62% | -$104K | ﹤0.01% | 5214 |
|
2021
Q4 | $250K | Buy |
+10,914
| New | +$250K | ﹤0.01% | 4784 |
|
2021
Q3 | – | Sell |
-38
| Closed | – | – | 6755 |
|
2021
Q2 | $0 | Sell |
38
-2,213
| -98% | – | ﹤0.01% | 6667 |
|
2021
Q1 | $30K | Sell |
2,251
-1,496
| -40% | -$19.9K | ﹤0.01% | 5677 |
|
2020
Q4 | $76K | Buy |
+3,747
| New | +$76K | ﹤0.01% | 5275 |
|